Home>Topics>Finance>Food>Food And Drug Administration

Food And Drug Administration

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. Should You Buy Navidea Biopharmaceuticals?

    Headlines

    Tue, 30 Sep 2014

    grant for evaluation of Lymphoseek in cervical cancer. Navidea has also received an Orphan Drug designation from the U.S. FDA for use of Lymphoseek in head and neck cancers. Finally, the company has also entered into a development and commercialization

  2. BRIEF-Nemaris and Medicrea receive FDA clearance for SURGIMAP 2.0

    Headlines

    Tue, 30 Sep 2014

    * Announced on Monday that it has received 510 (k) clearance from the U.S. Food and Drug Administration ( FDA ) for the SURGIMAP 2.0 platform

  3. UPDATE 1-Salix's constipation drug gets approval for expanded use

    Headlines

    Mon, 29 Sep 2014

    Sept 29 (Reuters) - Salix Pharmaceuticals Ltd said the U.S. Food and Drug Administration approved an expanded use of its constipation treatment.

  4. FDA approves Salix/Progenics' Relistor

    Headlines

    Mon, 29 Sep 2014

    Following a successful Phase 3 trial, the FDA has approved Relistor for "the treatment of opioid-induced ..... license from developer Progenics (NASDAQ: PGNX ). Many expected FDA approval to arrive following a favorable July ruling . PGNX

  5. FDA approves expanded use of Salix Pharma's constipation drug

    Headlines

    Mon, 29 Sep 2014

    Sept 29 (Reuters) - Salix Pharmaceuticals Ltd said the U.S. Food and Drug Administration approved an expanded use of its constipation treatment.

  6. Celgene Has A Very Bright Future Ahead

    Headlines

    Mon, 29 Sep 2014

    nearly 3% on Tuesday, following the news that the U.S. Food and Drug Administration approved its drug Otzela for the oral treatment of psoriasis ..... Morningstar Recently, the company announced that the FDA approved the expanded use of its drug Otzela as an oral

  7. FDA's Decision On Imbruvica Will Push Pharmacyclics Higher

    Headlines

    Mon, 29 Sep 2014

    By Mix Star : Background: The FDA decision on Pharmacyclics' (NASDAQ: PCYC ) IMBRUVICA, for a full ..... has just undergone clinical trial and is being deliberated by the FDA as a single agent for the treatment of patients with chronic lymphocytic

  8. Update: Cynosure Received FDA Clearance For PicoSure

    Headlines

    Mon, 29 Sep 2014

    By Andy Batts : Cynosure (NASDAQ: CYNO ) received FDA 510(k) clearance to market its flagship PicoSure Picosecond ..... PicoSure became the world's first picosecond device to receive FDA clearance for the removal of tattoos and benign pigmented lesions

  9. Insys cannabidiol tagged an Orphan Drug for glioma

    Headlines

    Mon, 29 Sep 2014

    The FDA designates Insys Therapeutics' ( INSY +2% ) pharmaceutical cannabidiol an Orphan Drug for the treatment of glioma . The designation qualifies the firm for certain financial incentives and a seven-year period of exclusivity if approved. Post your comment!

  10. FDA clears Ozurdex label expansion

    Headlines

    Mon, 29 Sep 2014

    The FDA approves a label expansion for Allergan's ( AGN +0.8% ) Ozurdex (dexamethasone intravitreal implant) for the treatment

« Prev12345Next »
Content Partners